B7-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of B7-1 Antibodies for research in immunology and cell biology. Monoclonal B7-1 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). B7-1, also known as CD80, plays a crucial role in the regulation of T-cell activation and is essential for the immune response. It serves as a co-stimulatory molecule that interacts with CD28 and CTLA-4 on T cells, influencing their proliferation and differentiation. Understanding the function of B7-1 is vital for developing therapeutic strategies in cancer immunotherapy and autoimmune diseases. B7-1 monoclonal antibodies enable detailed investigation of immune system regulation and cellular signaling pathways. Researchers working with B7-1 can gain valuable insights into immune checkpoint mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal B7-1 antibodies support scientists worldwide in advancing immunology research and developing new therapeutic approaches.